ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,970.84
-1.11%
US Tech 100
20,897.20
-1.35%
Dow Jones
42,992.21
-0.77%
Brent Oil
73.44
0.00%
Bitcoin
94,991.97
-0.16%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Virbac SA (VIRP) Quote

Virbac SA

Virbac SA (VIRP)

EU
316.50
6.50
(2.10%)
Closed December 29 11:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
316.50
Bid
311.50
Ask
318.00
Volume
2,847
309.50 Day's Range 318.00
306.00 52 Week Range 400.00
Market Cap
2.672B
Previous Close
310.00
Open
310.50
Last Trade
8
@
316.5
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
4,162
Shares Outstanding
8,443,062
Dividend Yield
0.42%
PE Ratio
22.03
Earnings Per Share (EPS)
14.37
Revenue
1.26B
Net Profit
121.3M

About Virbac SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.virbac.com
Headquarters
Carros, Fra
Founded
1968
Virbac SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker VIRP. The last closing price for Virbac was 310.00 €. Over the last year, Virbac shares have traded in a share price range of 306.00 € to 400.00 €.

Virbac currently has 8,443,062 shares outstanding. The market capitalization of Virbac is 2.62 € billion. Virbac has a price to earnings ratio (PE ratio) of 22.03.

Ask ADVFN Intelligence (AI)

VIRP Latest News

More News

Virbac : Declaration of the number of shares and voting rights 11/2024

Virbac : Declaration of the number of shares and voting rights 11/2024 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares...

December 06 2024
UK Regulatory

Virbac : Déclaration d'actions et de droits de vote 11/2024

Virbac : Déclaration d'actions et de droits de vote 11/2024 DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions...

December 06 2024
UK Regulatory

Virbac: Türkiye: Virbac acquires its companion animal distributor

Virbac: Türkiye: Virbac acquires its companion animal distributor On December 2, we finalized the acquisition of Turkish company Mopsan, specialized in the distribution of petfood and companion...

December 03 2024
UK Regulatory

VIRBAC: Turquie : Virbac acquiert son distributeur de produits pour animaux de compagnie

VIRBAC: Turquie : Virbac acquiert son distributeur de produits pour animaux de compagnie     Le 2 décembre, nous avons finalisé l'acquisition de la société turque Mopsan, spécialisée dans la...

December 03 2024
UK Regulatory

Virbac : Déclaration d'actions et de droits de vote 10/2024

Virbac : Déclaration d'actions et de droits de vote 10/2024 DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions...

November 06 2024
UK Regulatory

Virbac : Declaration of the number of shares and voting rights 10/2024

Virbac : Declaration of the number of shares and voting rights 10/2024 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares...

November 06 2024
UK Regulatory

Virbac: Strong revenue growth as of the end of September at +12.6% and +8.6% at constant exchange rates and scope. 2024 targets maintained.

Virbac: Strong revenue growth as of the end of September at +12.6% and +8.6% at constant exchange rates and scope. 2024 targets maintained. KEY FIGURES Revenue at the end of September   €1 042.1M...

October 17 2024
UK Regulatory

VIRBAC: Croissance soutenue du chiffre d’affaires à fin septembre de +12,6% et +8,6% à taux de change et périmètre constants. Maintien des objectifs pour 2024.

VIRBAC: Croissance soutenue du chiffre d’affaires à fin septembre de +12,6% et +8,6% à taux de change et périmètre constants. Maintien des objectifs pour 2024. CHIFFRES CLÉS Chiffre d’affaires à...

October 17 2024
UK Regulatory

Virbac : Déclaration d'actions et de droits de vote 09/2024

Virbac : Déclaration d'actions et de droits de vote 09/2024 DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions...

October 03 2024
UK Regulatory

Virbac : Declaration of the number of shares and voting rights 09/2024

Virbac : Declaration of the number of shares and voting rights 09/2024 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares...

October 03 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
161.93236714976310.53183062362309.96091435DE
4-5-1.55520995334321.53303062856317.8686739DE
12-51.5-13.99456521743684003064162343.75076161DE
26-18-5.38116591928334.54003063590351.6485731DE
52-34-9.70042796006350.54003063847349.42318391DE
156-98.5-23.7349397594154422155043315.31738182DE
2607531.0559006211241.5448.5132.25695283.54414637DE

VIRP - Frequently Asked Questions (FAQ)

What is the current Virbac share price?
The current share price of Virbac is 316.50 €
How many Virbac shares are in issue?
Virbac has 8,443,062 shares in issue
What is the market cap of Virbac?
The market capitalisation of Virbac is EUR 2.62B
What is the 1 year trading range for Virbac share price?
Virbac has traded in the range of 306.00 € to 400.00 € during the past year
What is the PE ratio of Virbac?
The price to earnings ratio of Virbac is 22.03
What is the cash to sales ratio of Virbac?
The cash to sales ratio of Virbac is 2.11
What is the reporting currency for Virbac?
Virbac reports financial results in EUR
What is the latest annual turnover for Virbac?
The latest annual turnover of Virbac is EUR 1.26B
What is the latest annual profit for Virbac?
The latest annual profit of Virbac is EUR 121.3M
What is the registered address of Virbac?
The registered address for Virbac is 1ERE AVENUE 2065 M LID, CARROS, 06516
What is the Virbac website address?
The website address for Virbac is www.virbac.com
Which industry sector does Virbac operate in?
Virbac operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALEMSEuropean Medical Solutions
6.70 €
(37,122.22%)
40
CFNCofina SGPS SA
15.95 €
(2,146.48%)
2.17k
DMSBSDiagnostic Medical Systems
0.003 €
(50.00%)
52k
ALTROTronic s Microsystems
5.00 €
(48.81%)
8
SEQUASequana medical NV
3.87 €
(40.22%)
2.43M
EIFDSTour Eiffel DS
0.0184 €
(-57.41%)
110.23k
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
ALMEXMexedia SPA
5.00 €
(-23.08%)
40
ALEUPEuroplasma
0.0413 €
(-14.67%)
3.93M
MLFMVFarminveste
1.20 €
(-14.29%)
1.36k
ATOAtos SE
0.0027 €
(17.39%)
3.02B
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
NEOENNeoen SA
39.83 €
(0.73%)
81.42M
BCPBanco Comercial Portugues SA
0.4602 €
(2.04%)
75.06M
ALHPIHopium SA
0.005 €
(0.00%)
19.56M

Discussion

View Full Feed
flipper44 flipper44 10 minutes ago
Here is a simple question. Viewing the two filings on December 26, how much did/will NWBO receive prior to January 1, and how much in addition to that before February 1, and what is the monthly burn rate?
NWBO
mascale mascale 17 minutes ago
Hiru itself is recently now locally connected in Tasmania, from a basis with likely connections to Qatar-based experience and connections. That part has so far not been widely noted. There is considerable international mining expertise, Qatar connected.
HIRU
flipper44 flipper44 21 minutes ago
Ex has always said, for years, 99% chance it will not be approved. His goal since he got here is to convince people it won’t. One of his backup profiles, investor082, covers a different angle. He states there will be approval but no financing.
NWBO
GrantHorvat1 GrantHorvat1 24 minutes ago
"Chart is a disaster"

Tells me all I need to know ffs lol...

Not that I didn't know it already about you...

Youre a WEIRDO...

GVSI
SkeBallLarry SkeBallLarry 33 minutes ago
At least 124 dead after plane crashes >

while landing in South Korea
https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
SkeBallLarry SkeBallLarry 34 minutes ago
At least 124 dead after plane crashes >

while landing in South Korea
https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
Phoenix2020 Phoenix2020 34 minutes ago
Friday's daily short sale volume was 74.61% (as reported by FINRA) and it seems that the shorts are trying hard to manipulate the market! The short borrow fee is 12.87% and the shorts have increased their position by another 600'000 shares to 6.14 million shares that are currently shorted. It should
CVM
SkeBallLarry SkeBallLarry 35 minutes ago
At least 124 dead after plane crashes >

while landing in South Korea
https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
SkeBallLarry SkeBallLarry 36 minutes ago
At least 124 dead after plane crashes >

while landing in South Korea
https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
cowtown jay cowtown jay 36 minutes ago
Here's a partial transcript of a discussion between Dr. John Campbell and Dr. Angus Dalgleish regarding a drug similar to lenz.

"21:17
we've done the phase one phase two is does it work every single phase two study we've done it clearly is of
21:23
benefit phase t
SkeBallLarry SkeBallLarry 38 minutes ago
At least 124 dead after plane crashes >

while landing in South Korea
https://abcnews.go.com/International/2-rescued-28-killed-after-jet-veers-off/story?id=117171549
Nrdc92 Nrdc92 53 minutes ago
Written like someone who doesn't have a clue, Jeunke. Beyond the rampant speculation in your post, it is ludicrous to believe that LWLG is in Tier 1 negotiations. No company during critical, major negotiations jettisons a respected  scientist and the company's CEO without a meaningful public explana
LWLG
Alexulf Alexulf 1 hour ago
Steve Reinharz: A Visionary Leader in AI and Security Innovation


Steve Reinharz, the CEO and CTO of Artificial Intelligence Technology Solutions (AITX), is a true visionary in the field of AI and security innovation. His passion for developing AI-powered, autonomous security s
AITX
Iggy_Bot Iggy_Bot 1 hour ago
If i can answer for Kash, the answer would be Nothing as usual. feckless
FireMechanic FireMechanic 1 hour ago
Tne dow isn't 43,000 and Bitcoin isn't 100K!!! The current administration is working with the right people to keep these numbers. Unfortunately they will drop this in trump administration lap and say it's his fault. Gonna be millions of people in the world hurting soon mostly because of our crooked
BTCUSD
theswordman theswordman 1 hour ago
💯
CKPT
janetcanada janetcanada 1 hour ago
***I have been reading this in the past???....

1️⃣ 5 cents. Nickel.
2️⃣10 cents. Dime.
3️⃣ 25 cents Quarter.
4️⃣1 dollar.
RDAR
theswordman theswordman 1 hour ago
The official answer is at clinical trials . gov.

Trial NCT06699836

It is a PH II with est start FEB 2025

est finish JUN 2028

60 patients. Last update 21 NOV 2024

This is an open label, randomized, two arm, multi-center study
MSS
123tom 123tom 1 hour ago
Looking at the chart, I'm thinking first the 10 to 9 area, in the next wave down. It would look discouraging to see a great rally from 8.50 to 14.50 fall all the way back down... that wouldn't feel like how a good news rally should be. I'd be ok to watch it hold at 10-11 and begin the next surge
AVXL
NocRob NocRob 1 hour ago
Those options are all for Berman at $0.21 with a sweetener around an acquisition. Both that strategy and Berman in general have proven to be complete busts. But if this somehow pushes past $0.21, I’m out and never looking back.
BLPG
wallstreet1231 wallstreet1231 2 hours ago
There has been nothing to cheer about.

Zero sales last two reporting period.

Filings still delinquent - what, over a year now.

A manufacturing facility-where?Me no see.

Oh, and a manufacturing facility - where?

And now chee
SNPW
demonsmith demonsmith 2 hours ago
Should I sale to you at 0.02
HLLK
LEFTY1182 LEFTY1182 2 hours ago
Where did he say that at?
RSPI
Plato_ Plato_ 2 hours ago
You're right MasterBlastr. Some here, with very large positions, have already announced that when the price hits 0.016 they will be "dumping stock on the market."
Between middle of July and end of September, I picked up millions and millions of millions of shares, at some point I recall a tr
GDVM

Your Recent History

EU
VIRP
Virbac
BIT
S29110
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads